This compound is a ruthenium-based asymmetric hydrogenation catalyst, commonly used in research laboratories for enantioselective synthesis. Its structure features a chiral sulfonylazanide ligand coordinated to ruthenium, along with mesitylene as a stabilizing ligand.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 174813-81-1
(R)-[2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl dichlororuthenium
asymmetric hydrogenation catalyst
(S)-RuCl[(p-cymene(BINAP)Cl
asymmetric hydrogenation catalyst
5'-Deoxy-5'-methylthioadenosine-d3
deuterated research reference standard
(4S)-Methyl-[1,3,2]dioxathiolane 2,2-dioxide
research compound
1,3,5-tribromo-1,3,5-triazinane-2,4,6-trione
bromination reagent in organic synthesis
6-(tert-butyl)pyrimidine-2,4-diamine
Research compound
RuCl[(R,R)-TsDPEN](mesitylene)
asymmetric hydrogenation catalyst
[(1S,2S)-2-Amino-1,2-diphenylethyl]-(2,3,4,5,6-pentafluorophenyl)sulfonylazanide;1-methyl-4-propan-2-ylbenzene;ruthenium(2+);chloride
asymmetric hydrogenation catalyst
[(1S,2S)-2-amino-1,2-diphenylethyl]-(4-methylphenyl)sulfonylazanide;chlororuthenium(1+);1,3,5-trimethylbenzene
XBNBOGZUDCYNOJ-XCPIVNJJSA-M
CC1=CC=C(C=C1)S(=O)(=O)[N-][C@@H](C2=CC=CC=C2)[C@H](C3=CC=CC=C3)N.CC1=CC(=CC(=C1)C)C.Cl[Ru+]
—